Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Non-Invasive Colorectal Cancer Screening

BACKGROUND: Biomarker assays could increase the accuracy of non-invasive detection of colorectal cancer (CRC); fecal immunochemical tests (FITs) are estimated to miss 27%–47% of CRCs and 70%–80% of advanced adenomas per round of screening. We investigated the conditions under which biomarker screens...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Gastroenterol Hepatol
Autors principals: Lansdorp-Vogelaar, Iris, Goede, S. Lucas, Bosch, Linda J.W., Melotte, Veerle, Carvalho, Beatriz, van Engeland, Manon, Meijer, Gerrit A., de Koning, Harry J., van Ballegooijen, Marjolein
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5773413/
https://ncbi.nlm.nih.gov/pubmed/28733262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2017.07.011
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars